$NKE

Nike cut to Neutral by Piper Sandler; PT lowered to $38 (NKE:NYSE)

Piper Sandler downgraded Nike (NKE) to Neutral, lowering its price target to $38 from $45. The firm expects promotional pressures and weaker footwear demand to delay Nike's recovery. The new target implies a 6.3% upside from the last close.

Original reporting
Published Sep 28, 2026, 4:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 5:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$NKE
Bearish
high confidence
Mentioned
$NKE
Relevance
7/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$NKEBearishMed
01

Why it matters

The downgrade signals a shift in earnings expectations, potentially prompting short‑term sell pressure.

02

Market read

Analyst target cuts are a common catalyst for equity price moves, especially for a large‑cap consumer brand like Nike.

03

What to watch

Potential upside from international market recovery and digital sales acceleration.

Relevance 7/10Novelty 7/10Timing: post‑market today

Background

Piper Sandler revised its outlook for Nike amid a broader slowdown in athletic footwear demand.

Company-level read

Ticker impact

$NKEBearishHigh confidence
Context

Piper Sandler lowered Nike's price target to $38 from $45, citing weaker athletic footwear demand.

Expected impact

likely downside as market prices in weaker demand expectations

Evidence & confidence

Target cut reflects a tangible change in earnings expectations; analysts' views often move the stock in the short term.

Market effects

May weigh on broader apparel and footwear sector as peers face similar demand concerns.

U.S. consumer discretionary sentiment could soften.

Limited to Nike and its supply chain; no immediate global macro effect.

Counterpoint

Nike's brand strength and upcoming product launches could offset short‑term demand softness.

Key entities

  • Nike

    Global sportswear and equipment manufacturer.

  • Piper Sandler

    Investment bank providing equity research coverage.

Related articles

$NKEMed

Piper Sandler cuts Nike stock price target on worsening trends

Piper Sandler reduced its Nike (NKE) price target to $38 from $45, citing weaker sales guidance and a tough promotional environment. The stock is near its 52-week low, down 42% year-to-date. Piper Sandler lowered its Q1 fiscal 2027 sales estimate to -3% and EPS to $0.37, below consensus. Nike's Q1 earnings are due October 1, 2026. Analysts have mixed outlooks on the company's performance and valuation.

$NKEHigh

Why Did NKE, PEP, FRMI Stocks Dip To 52-Week Lows Last Week?

Nike (NKE) fell to a 52-week low after a BofA downgrade, citing earnings risks and a longer-than-expected turnaround. PepsiCo (PEP) also hit a 52-week low due to rising costs and weak North American sales, though it closed higher. Fermi (FRMI) dropped amid cash burn and CEO disputes. NKE, PEP, and FRMI stocks are down 43%, 9%, and 49% YTD, respectively.

$NKEHighAI 8/10

Nike stock falls to a decade low as Wall Street stops believing the turnaround story

Nike stock hit a 12-year low at $35.22. Bank of America downgraded Nike to Underperform with a $30 target, citing expected negative sales growth and inventory issues. Nike's shares are down 40% in 2026 and 80% since 2021. The company faces challenges in China and competition from Adidas, which gained market share. BofA also noted potential dividend sustainability issues.

$NKEMed

Nike Bank of America downgrade 2026

Bank of America downgraded Nike to Underperform, cutting its price target to $30 from $47. Analyst Lorraine Hutchinson delayed sales recovery expectations to fiscal 2028, reducing EPS estimates. China revenue fell 17% in Q4, and wholesale partners face inventory issues. Nike shares have dropped over 40% since January, nearing 52-week lows.